Clinicopathologic and Molecular Analysis of Primary Angiosarcoma of Bone—A Single Institution Experience Journal Article
| Authors: | Hirose, T.; Chang, H. Y.; Lefkowitz, R. A.; Healey, J.; Antonescu, C. R. |
| Article Title: | Clinicopathologic and Molecular Analysis of Primary Angiosarcoma of Bone—A Single Institution Experience |
| Abstract: | Purpose: Bone angiosarcoma (B-AS) is an exceedingly rare and aggressive vascular neoplasm, with limited therapeutic options and poor outcomes. Unlike the more prevalent clinical subsets (breast, head and neck), the pathogenesis of B-AS remains poorly defined, with no targeted therapeutic strategies available. Moreover, the often delays in diagnosis, either radiographically or pathologically, as well as the common multifocal presentation, further impact the feasibility of surgical management, contributing to lower survival rates. In this study, we investigated the clinicopathologic and molecular characteristics of B-AS to better define prognostic factors influencing outcomes. Patients and Methods: This retrospective study analyzed 22 cases of B-AS managed at a single tertiary cancer center from 1998 to 2024. Clinical and pathologic data were extracted through chart reviews and re-assessment of radiology and histology. Molecular characterization was performed in a subset using targeted next-generation sequencing (NGS). Results: The cohort included 14 males and eight females (median age: 64.5 years), with tumors mostly involving femur, pelvis, and spine. Twelve (55%) patients presented with disease limited to the bone, either solitary or multifocal, while 10 (45%) patients presented in addition with extraskeletal metastases at diagnosis. The skeletal distribution included six (27%) solitary bone lesions, with the remaining 16 being multifocal (four contiguous, twelve disseminated). A surgical procedure for the bone lesions was performed in 73% of cases, varying from intralesional curetting to limb amputation. Half of the patients received radiation, and 73% chemotherapy. By molecular profiling, all tumors showed a low tumor mutational burden (TMB), with the most frequent alterations being KDR mutations and MYC amplifications. Age and chemotherapy were significantly associated with improved overall survival (OS) (p < 0.005); however, the 3-year OS was only 30%. Conclusion: Despite the multidisciplinary approach and orthopedic oncology expertise from a tertiary cancer center, the prognosis for B-AS remains poor. Although limited in number, the molecular profiling revealed overlapping genomic alterations with other clinical subsets of AS, having the potential for individualized patient management. © 2025 Wiley Periodicals LLC. |
| Keywords: | adult; cancer chemotherapy; clinical article; treatment outcome; aged; aged, 80 and over; bone neoplasms; middle aged; bone tumor; survival rate; retrospective studies; gene mutation; overall survival; genetics; mutation; sorafenib; doxorubicin; gemcitabine; paclitaxel; cancer radiotherapy; treatment; follow up; gene; ipilimumab; gene amplification; tumor volume; etoposide; cohort analysis; pathology; angiosarcoma; hemangiosarcoma; medical record review; oncology; retrospective study; tumor marker; risk factor; histology; ifosfamide; docetaxel; patient care; liver metastasis; lung metastasis; bone lesion; clinical study; pelvis tumor; bone; brain metastasis; genomics; outcome; therapy; orthopedics; oncogene myc; femur tumor; bone radiography; bone cancer; spine tumor; soft tissue metastasis; limb amputation; kyphoplasty; en bloc resection; molecular; olaratumab; cancer prognosis; high throughput sequencing; multifocality; high-throughput nucleotide sequencing; spleen metastasis; nivolumab; very elderly; humans; prognosis; human; male; female; article; pembrolizumab; tertiary care center; orthopedic oncology; bone angiosarcoma; biomarkers, tumor; larotrectinib; kdr gene; tumor mutational burden; molecular fingerprinting; hip disarticulation |
| Journal Title: | Genes Chromosomes and Cancer |
| Volume: | 64 |
| Issue: | 6 |
| ISSN: | 1045-2257 |
| Publisher: | Wiley Periodicals, Inc |
| Date Published: | 2025-01-01 |
| Start Page: | e70056 |
| Language: | English |
| DOI: | 10.1002/gcc.70056 |
| PUBMED: | 40492503 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Article -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work